News
Laura Esserman Named to TIME 100 List of Most Influential People in the World
Time magazine has named internationally renowned breast cancer oncologist Laura Esserman, MD, MBA, to the 2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world. Esserman has been at the forefront of efforts to change the delivery of breast cancer services as well
New UCSF Center for BRCA Research Expands Care for Increased Cancer Risk
As more people get their hands on their own genetic data each day, many face an increasingly common question: What do you do if you carry a genetic risk factor for cancer? While knowing genetic mutations can help clinicians decide on treatment options for patients, the data raises more questions
Stand Up To Cancer Supports Innovative Research Grants for 10 Early-Career Scientists
NEW ORLEANS — Stand Up To Cancer (SU2C) announced Monday that it is awarding 10 grants of $750,000 each to early-career scientists to support innovative, high-risk, high-reward projects in cancer research. The announcement was made at the 2016 Annual Meeting of the American Association for Cancer
Gene Mutation Makes Tumors Tense, Worsens Patient Prognosis
UC San Francisco researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are. The researchers provide the first evidence linking tumor aggressiveness and
New Cancer Immunotherapy Clinic Offers Unique Studies of Promising Treatments
UC San Francisco oncologist Lawrence Fong, MD, personifies the tremendous excitement among cancer physicians over the growing potential of new immunotherapies. He smiles often as he explains how the body’s own immune system – long thought to be an ineffective slacker when it comes to combatting
UCSF Immunologist to Head New Parker Institute for Cancer Immunotherapy
Renowned UC San Francisco immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, a private philanthropic organization established by Silicon Valley
American Association for Cancer Research Elects UCSF Faculty to Board of Directors, Nominating Committee
PHILADELPHIA — The members of the American Association for Cancer Research (AACR) have elected five members to serve on the AACR Board of Directors for the 2016-2019 term and four members to serve on the nominating committee for the 2016-2018 term. They will begin their terms at the AACR Annual